This message was sent to ##Email##
|
|
|
|
|
STAT
When the Food and Drug Administration issued guidelines for investigative stem cell therapies, much of the attention fell to the agency's vow to crack down further on unregulated clinics offering potentially unsafe treatments.
But the guidances also have plenty of ramifications for companies trying to bring to market innovative and legitimate stem cell treatments by moving them through clinical trials and getting them approved by the FDA.
READ MORE
University of Salford via Medical Xpress
Cancer researchers seeking nontoxic alternatives to harmful chemotherapy are reporting a highly significant result for a humble cold remedy. N-Acetyl cysteine is routinely used as a dietary supplement and as a decongestant given to children to ward off a cold.
READ MORE
Streck, Inc.
Learn how customized clinical samples provided by Conversant Bio in Streck Cell-Free DNA BCT® have helped accelerate their cancer research for one of their biotech clients. Conversant Bio is on a mission to develop a liquid biopsy test for early cancer detection in order to increase cancer survivor rates. They were able to buy an additional 48 hours to process samples due to the use of Streck Cell-Free DNA BCT®.
READ MORE
|
|
Medical News Today
New research reveals how a dysfunction in the brain's so-called self-digestion system leads to cell death in neurodegenerative disorders. The newly discovered mechanism may lead to new therapies for conditions such as Parkinson's and Alzheimer's disease.
READ MORE
|
Promoted by
|
|
|
|
 |
Michigan Medicine - University of Michigan via ScienceDaily
Killer bacteria — ones that have out-evolved our best antibiotics — may not go away anytime soon. But a new approach to tracking their spread could eventually give us a fighting chance to keep their death toll down.
READ MORE
 |
|
Performance, reporting, and QA recommendations for identification of cultured microorganisms take the guesswork out of introducing MALDI-TOF into your laboratory. CLSI’s M58 includes recommendations for end-user verification and workflow integration, along with best practices for quality and safety.
Visit clsi.org/m58/ for more information.
|
|
Reuters via Fox News
The U.S. Food and Drug Administration approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at easing the side effects for long-term patients who are on the standard treatment involving three or more drugs.
The treatment, called Juluca, is a fixed-dose tablet that combines two previously approved drugs, dolutegravir and rilpivirine, and is available to patients who have been on a stable regimen for at least six months.
READ MORE
Singularity Hub
It started like any other day. Dr. Hao Yin walked into the lab at MIT, ready to check on his transgenic mice. He had no idea he was about to make history.
READ MORE
|
Promoted by
|
|
|
|
 |
Infection Control Today
The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients with Zika-related complications, such as Guillain-Barré syndrome, the researchers said.
READ MORE
|
|
Medical News Today
Chloroquine and hydroxychloroquine are drugs that are used to treat malaria, but a new review suggests that they may have another purpose: treating cancer.
The research — which reviewed more than 190 studies investigating how chloroquine and hydroxychloroquine affect cancer cells — describes how the malaria drugs may increase tumor sensitivity to existing cancer treatments.
READ MORE
 |
|
The LIAISON® Treponema assay is your solution for automating syphilis testing. Improve sensitivity and specificity over RPR screening using our fully-automated LIAISON® XL platform. The LIAISON® Treponema assay detects both IgG and IgM antibody response to T. pallidum infections. Visit www.diasorin.com for more information.
|
|
DARK Daily
It is good news for the anatomic pathology profession that new insights into the human immune system are triggering not only a wave of new therapeutic drugs, but also the need for companion diagnostic tests that help physicians decide when it is appropriate to prescribe immunotherapy drugs. Rapid advances in precision medicine, and the discovery that a patient's own immune system can be used to suppress chronic disease, have motivated pharmaceutical companies to pursue new research into creating targeted therapies for cancer patients.
READ MORE
|
This webinar series provides an introduction for laboratory technologists. Participants develop the knowledge and skills necessary to perform and interpret antimicrobial susceptibility and report results.
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
Penn State via Lab Manager
Flies can be more than pesky picnic crashers, they may be potent pathogen carriers, too, according to an international team of researchers.
In a study of the microbiomes of 116 houseflies and blowflies from three different continents, researchers found, in some cases, these flies carried hundreds of different species of bacteria, many of which are harmful to humans.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
